Get started
Author

Gina A. Reynolds

Observed names: Gina A Reynolds, Gina Reynolds
Institution: Mayo Clinic
OpenAlex ID: A5025532015
Durable Complete Response With Immune Checkpoint Inhibitor in Breast Cancer With High Tumor Mutational Burden and APOBEC Signature
2020 · Saranya Chumsri, Ethan S. Sokol, et al. · Journal of the National Comprehensive Cancer Network · 43
Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients
2021 · Saranya Chumsri, Pooja P. Advani, et al. · Mayo Clinic Proceedings Innovations Quality & Outcomes · 13
Rifaximin for Pertuzumab-Related GI Toxicities
2017 · Aixa E. Soyano, Gina Reynolds, et al. · Frontiers in Oncology · 9
PDF
PD-1/PD-L1 expression and molecular associations in HPB malignancies.
2016 · Kabir Mody, Rebecca Feldman, et al. · Journal of Clinical Oncology · 8
Case Report: Alpelisib-Induced Drug Reaction With Eosinophilia and Systemic Symptoms: A Rare Manifestation of a Common Side Effect
2021 · Umair Majeed, Tudor Puiu, et al. · Frontiers in Oncology · 6
PDF
Long-term cellular and humoral responses to SARS-CoV-2 vaccinations in patients with solid malignancies undergoing chemotherapy
2026 · Andrew Liu, Brian Necela, et al. · Frontiers in Immunology · 3
PDF
143 Long-term cellular and humoral responses to SARS-CoV-2 vaccinations in patients with solid malignancies undergoing chemotherapy
2024 · Andrew Liu, Brian Necela, et al. · Regular and Young Investigator Award Abstracts
Abstract P3-23-01: Antibody responses after SARS-CoV-2 mRNA vaccination in breast cancer patients
2022 · Saranya Chumsri, Pooja P. Advani, et al. · Cancer Research
Works count: 8
Citation count: 82
H-index: 5
I10-index: 2
Year
Topic
Type